Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RVX000222 phase IIb IVUS plaque study in coronary artery disease
NL-OMON35848Phase 2Active, not recruiting
- Sponsor
- Resverlogix Corp.
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronary arteriosclerosis comparing RVX000222 plus standard therapy with Placebo plus standard therapy (2 arms). Started Mar 2012; status: active, not recruiting.
02
Drugs
apabetalone
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on NL-OMON35848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35848.